急性低危肺栓塞门诊管理的采纳情况
该研究在单中心急诊科实施多组分干预,采用RE-AIM框架评估低危肺栓塞门诊管理的采纳情况。研究纳入1,810例急性肺栓塞患者,其中705例(39.0%)为低PESI评分(≤85)。干预后低PESI患者急诊出院比例从实施前的5.1%上升至维持期的33.3%(OR 9.24,95%CI 5.04-16.92)。所有急诊出院患者30天内无复发静脉血栓栓塞或死亡,出血并发症罕见(0%-4.3%)且无需住院。排除Hestia阳性病例后,采纳率从9.0%升至维持期的75%。
要点
- 低PESI(≤85)急性肺栓塞患者中,多组分干预使急诊出院比例从5.1%持续升至33.3%(OR 9.24,95%CI 5.04-16.92)。
- 排除Hestia阳性病例后,低PESI患者急诊出院采纳率从9.0%升至维持期的75%。
- 所有急诊出院的低危肺栓塞患者30天内无复发静脉血栓栓塞或死亡。
- 出血并发症罕见(0%-4.3%),且无一例需要住院。
- 住院减少主要见于低PESI且无Hestia标准的患者,而低PESI但Hestia阳性者的住院率保持相对稳定。
适用人群与场景
- 急诊科就诊的急性肺栓塞患者,低PESI评分≤85(低危)者;单中心四级学术医疗中心。
- 原文未明确列出排除人群。
诊断标准与关键阈值
- 低危肺栓塞定义:PESI评分≤85。
- Hestia标准用于进一步筛选适合门诊管理的患者(原文未列出具体条目)。
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径或疗程。
- 多组分干预针对低危肺栓塞门诊管理的关键障碍,具体组成原文未详述。
红旗征与不能漏的情况
- Hestia阳性低PESI患者住院率未下降,提示这些患者可能不适合门诊管理。
研究设计与关键结果
- 单中心实施研究,纳入1,810例急性肺栓塞患者,其中705例(39.0%)为低PESI(≤85)。
- 主要结局(采纳率)从实施前5.1%升至第I年16.1%(OR 3.43,95%CI 1.77-6.63)、第II年24.0%(OR 5.98,95%CI 3.04-11.78)、第III年33.3%(OR 9.24,95%CI 5.04-16.92)。
- 所有急诊出院患者30天内无复发静脉血栓栓塞或死亡;出血并发症罕见(0%-4.3%),无需住院。
- 排除Hestia阳性病例后,采纳率从9.0%升至维持期75%。
证据类型、等级与局限
- 单中心实施研究(非随机),采用RE-AIM框架评估,证据等级原文未提及。
- 局限:单中心、非随机设计、样本来自单一学术医疗中心,结果外推需谨慎。
对床旁实践的改变
- 在急诊科对低PESI(≤85)急性肺栓塞患者,可考虑多组分干预促进门诊管理,但需结合Hestia标准筛选。
- Hestia阳性低PESI患者住院率未下降,提示不应常规门诊管理。
- 实施过程中需监测出血和血栓复发,原文显示出血罕见且无需住院,30天内无复发或死亡。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: To assess longitudinal outcomes of a multicomponent intervention designed to address key barriers to the outpatient management of low-risk pulmonary embolism (PE), and to define the most appropriate target population and metric for evaluating adoption.
METHODS: We implemented a multicomponent intervention in the emergency department (ED) of a quaternary academic medical center. Outcomes were evaluated using the RE-AIM framework, comparing a 3-year preimplementation period (2016-2019) with active implementation (year I), postimplementation (year II), and maintenance (year III) periods. The primary outcome (adoption) was the proportion of low-PESI (≤85) patients discharged from the ED. Following implementation, the charts of all hospitalized low-PESI patients were reviewed to determine reasons for admission.
RESULTS: Among 1,810 patients with acute PE, 705 (39.0%) had low-PESI scores. Adoption rose from 5.1% preimplementation to 16.1% (odds ratio [OR] 3.43, 95% confidence interval [CI] 1.77 to 6.63), 24.0% (OR 5.98, 95% CI 3.04 to 11.78), and 33.3% (OR 9.24, 95% CI 5.04 to 16.92) in years I to III. There were no recurrent venous thromboembolism or deaths within 30 days of any ED discharge. Bleeding complications were rare (0%-4.3%) and none required hospitalization. Hospitalization decreased primarily among low-PESI patients without Hestia criteria, whereas admission of low-PESI Hestia-positive patients remained relatively constant. Excluding Hestia-positive cases, adoption increased from 9.0% preimplementation to 75% in the maintenance phase.
CONCLUSION: In this single-center implementation study, a multicomponent intervention guided by RE-AIM resulted in a sustained increase in outpatient management of low-risk PE. Both the PESI score and Hestia criteria could be incorporated into the definition of the target population and future quality metrics.
参考来源
- Greineder CF, Mefford V, O'Hare C, et al. Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism. Ann Emerg Med. 2026. PMID: 42878715. doi:10.1016/j.annemergmed.2026.08.738
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。